CLINICAL TRIALS PROFILE FOR LOVASTATIN
✉ Email this page to a colleague
505(b)(2) Clinical Trials for LOVASTATIN
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT00092846 ↗ | A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2002-12-04 | The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for LOVASTATIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000463 ↗ | Post Coronary Artery Bypass Graft (CABG) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1987-04-01 | To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously. |
| NCT00000469 ↗ | Asymptomatic Carotid Artery Plaque Study (ACAPS) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 1988-05-01 | To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Also, to determine if a full scale trial was feasible. |
| NCT00000477 ↗ | Cholesterol Reduction in Seniors Program (CRISP) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 1990-07-01 | To conduct a pilot study to determine whether lowering elevated serum cholesterol levels with 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors reduced mortality due to the sequelae of atherosclerotic cardiovascular disease in older men and women. |
| NCT00000512 ↗ | Familial Atherosclerosis Treatment Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1984-01-01 | To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography. |
| NCT00000512 ↗ | Familial Atherosclerosis Treatment Study | Completed | University of Washington | Phase 3 | 1984-01-01 | To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography. |
| NCT00004346 ↗ | Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis | Unknown status | Oregon Health and Science University | Phase 2 | 1996-01-01 | OBJECTIVES: I. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in patients with cerebrotendinous xanthomatosis before and after a cholesterol- and cholestanol-free diet. II. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in these patients before and after lovastatin and chenodeoxycholic acid. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOVASTATIN
Condition Name
Clinical Trial Locations for LOVASTATIN
Trials by Country
Clinical Trial Progress for LOVASTATIN
Clinical Trial Phase
Clinical Trial Sponsors for LOVASTATIN
Sponsor Name
